Clinical Trial Detail

NCT ID NCT02304393
Title A Study of RO7009789 in Combination With MPDL3280A in Patients With Locally Advanced and Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

Therapies

Selicrelumab

Atezolizumab

Age Groups: adult

No variant requirements are available.